Full text is available at the source.
Abstract
Over 42% of U.S. adults are affected by obesity, yet access to metabolic and bariatric surgery remains limited.
- The use of GLP-1 receptor agonists has increased significantly in the last three years.
- In contrast, the volume of metabolic and bariatric surgeries has decreased by over 25% during this same period.
- Barriers to accessing metabolic and bariatric surgery include long wait times, societal stigma, fear of surgery, and insurance restrictions.
- This investigation focused on the accessibility of appointments and the requirements for patients seeking metabolic and bariatric surgery.
Simplified